ACUSON CORP

ACUSON CORP, operating under SIC 3841 in the Electromedical & Electrotherapeutic Apparatus sector, is recognized for its diagnostic ultrasound platforms and related service offerings that help hospitals, outpatient clinics, and specialty care providers enhance imaging accuracy and patient throughput; these systems range from portable scanners to comprehensive cart-based suites, often bundled with remote maintenance, clinical education, and workflow optimization services tailored to radiologists, cardiologists, and obstetrics teams. The company must balance innovation against the material risks inherent in developing and commercializing medical devices, including rigorous FDA and international regulatory clearances, supply-chain vulnerabilities for critical components, and the potential impact of reimbursement policy shifts on provider purchasing behavior, all while safeguarding data privacy and cybersecurity across connected imaging systems. Securities watchers can note the last SEC filing disclosed here was a Form 8-K submitted in December 1999, and for continued transparency, the profile is anchored by CIK 717014; view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025